Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

ADIL Adial Pharmaceuticals Inc

1,0005

-0,0195 (-1,91%)

Zuletzt aktualisiert: 16:11:22

Verzögert um 15 Minuten

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

null

Adial Pharmaceuticals (NASDAQ:ADIL)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

Click Here for more Adial Pharmaceuticals Charts.

Adial Pharmaceuticals (NASDAQ:ADIL)
Historical Stock Chart
Von Nov 2023 bis Nov 2024

Click Here for more Adial Pharmaceuticals Charts.

News Adial Pharmaceuticals Inc

Form 8-K - Current report
Montag 18 November 2024 (3 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 18 November 2024 (3 Tage vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Montag 18 November 2024 (3 Tage vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (7 Tage vor) • Edgar (US Regulatory)

Adial Pharmaceuticals Announces Positive Topline Results from the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
Donnerstag 14 November 2024 (1 Woche vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 13 November 2024 (1 Woche vor) • Edgar (US Regulatory)

Adial Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
Mittwoch 13 November 2024 (1 Woche vor) • GlobeNewswire Inc.

Form 8-K - Current report
Dienstag 12 November 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 5 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer
Dienstag 5 November 2024 (2 Wochen vor) • GlobeNewswire Inc.

Adial Pharmaceuticals to Present at the 2024 ThinkEquity Conference
Mittwoch 23 Oktober 2024 (4 Wochen vor) • GlobeNewswire Inc.

Adial Pharmaceuticals Receives Notice of Allowance for U.S. Patent Covering Expanded Genotype Combinations Identified Using the Company’s Genetic Diagnostic for Addiction Treatment
Donnerstag 17 Oktober 2024 (1 Monat vor) • GlobeNewswire Inc.

Weitere Adial Pharmaceuticals Inc News-Artikel

First Foundation

Walgreens Boots Alliance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen